• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.25% Nasdaq Up 0.65%

    Biogen Inc. (BIIB)

    -NasdaqGS
    282.79 Up 0.79(0.28%) May 27, 4:00PM EDT
    |After Hours : 282.79 0.00 (0.00%) May 27, 7:48PM EDT
    Prev Close:282.00
    Open:282.00
    Bid:280.70 x 600
    Ask:284.25 x 200
    1y Target Est:345.50
    Beta:0.3261
    Earnings Date:Jul 22 - Jul 26 (Est.)
    Day's Range:280.61 - 284.25
    52wk Range:242.07 - 420.99
    Volume:1,262,957
    Avg Vol (3m):1,619,730
    Market Cap:61.95B
    P/E (ttm):17.38
    EPS (ttm):16.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BIIBUp 0.28%61.95B
    PFEUp 0.52%209.90B
    ABTUp 1.05%57.74B

    Key Statistics

    Forward P/E (1 yr):14.08
    P/S (ttm):5.65
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :18.83
    Quarterly EPS Est (Jun-16) :4.66
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):1.59

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback